Drug Shortage Report for ACTEMRA

Last updated on 2021-11-26 History
Report ID 142457
Drug Identification Number 02424770
Brand name ACTEMRA
Common or Proper name ACTEMRA
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) TOCILIZUMAB
Strength(s) 162MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size pre-filled syringe
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-11-20
Actual start date
Estimated end date 2021-12-31
Actual end date 2021-11-25
Shortage status Resolved
Updated date 2021-11-26
Company comments During the COVID-19 pandemic, the demand for Actemra has been increasing at a global level. Roche has started to apply mitigation strategies to support our efforts to increase the supply of Actemra.
Health Canada comments
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-11-26 English Compare
v7 2021-11-25 French Compare
v6 2021-11-25 English Compare
v5 2021-11-21 English Compare
v4 2021-09-08 French Compare
v3 2021-09-08 English Compare
v2 2021-07-13 French Compare
v1 2021-07-13 English Compare